Humanwell Healthcare China

Humanwell is the market leader in anaesthetics/analgesics, fertility regulation drugs, and Uyghur medicine in Asia. It is also a major player with expanding product portfolio and market shares in treating central nerve system, respiratory and dermatological diseases in China.
Company Size (Fulltime employees)
Year of foundation
1993
Please specify your partnering goal
See above
Headquartner in China
Mr. Zhehang DENG
Executive Assistant 
Functionality
Roby Chen
投资部经理 

ICBC Asia Investment China

Private Equity investment platform of ICBC.

ICBC Asia investment is a wholly-owned holding equity investment platform of industrial and commercial bank of China (ICBC). Managing over 44 billion yuan unlist equity investment. Direct investment over 172 projects, indirect investment in over 2400 companies.

Website:
www.icbcamg.com
Partnering Objectives
Headquartner in China
Mr Kaijun Huang
LinkedIn logo Investment Director 
Functionality

Illumina Ventures United States

Illumina Ventures is an independently managed firm focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. Illumina Ventures invest in life science tools, clinical diagnostics, therapeutics, and other opportunities to improve human health.
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
deal sourcing
Headquartner in China
Wei Wu
Investor 

Innomed Capital China

A VC Capital focused on potential collaborations with and investments in early stage biotech.
Partnering Objectives
Headquartner in China
蓉 赵
合伙人 

Innovation center of high performance medical device China

IHM-GBA is an investor and an innovation center in Guangzhou, China. The firm is looking to invest in the medical device sector. The firm is highly focusing on investment and cooperation in high-performance innovative medical device companies. The firm also helps companies to enter the Chinese market.
Website:
www.ihm-gba.com
Partnering Objectives
Headquartner in China
Steve Wu
Bd director 

IQT United States

Strategic investor
Website:
www.iqt.org
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
investments
Headquartner in China
Mr. Eugene Chiu
Senior Partner 
Functionality

ISHA Therapeutics LLC United States

ISHA Therapeutics, is a unique organization with its primary location based out of New Jersey, exclusively focused on supporting clinical and translational development programs spanning from very early on to late stage developments. We provide consulting services to our esteemed clients who aspire to develop safe and efficacious new drugs, devices and biologicals. We also have our in-house innovative drug development pipeline.
Company Size (Fulltime employees)
Please specify your partnering goal
Out- license some technologies
Headquartner in China
Biotech/Pharma Category
Dr. Manoj Manoj
Founder and CEO 
Functionality

Jiangbei New area China

JIANGBEI NEW AREA IS THE 13rd national new area,and 1st in jiangsu province.
Partnering Objectives
Headquartner in China
Qin Liu
manager 

Jiangxi Jemincare Group Co., Ltd. China

One Top Chinese Pharma

Ben Yang
Business Development Manager 

JIAYUHONGDE INVESTMENT (SHANGHAI)Ltd China

Investment management company commits to authentic relationships, communications, and promises,builds productive operations and profitable businesses,invests in the field of medical technology, new energy source etc.
梦龄 徐
高级投资经理